The early interface reaction of cancellous bone to a nanocrystalline hydroxyapatite (HA) cement containing 3 wt% collagen type I (HA/Coll) with a setting under physiological temperature and pH was observed using immunohistochemical techniques. Pure HA served as a control. Cylinders with a diameter of 2 mm were implanted into the proximal tibia of 72 adult Wistar rats. Histological sections of 6 animals were prepared after 1, 2, 4, 6, 14 and 28 days. First, osteoblast-like cells as well as a marked reaction for osteonectin, osteopontin and its ligand CD44 were observed as early as 2 days after implantation at the interface around HA/Coll implants. Further, reactivity for ED1 and cathepsin D, both markers for phagocytotic cells, appeared earlier and stronger around HA/Coll. In cell counts, a significantly higher average number of ED1- and cathepsin D-positive phagocytotic cells was observed around the HA/Coll implants on days 6 (p < 0.01), 14 and 28 (p < 0.05). The number of osteopontin-positive cells was significantly higher around HA/Coll implants at days 6 and 14 (p < 0.05). Two weeks after the implantation, first islands of newly formed woven bone were observed around the HA/Coll implant, but not around the control implant. The amount of direct bone contact after 28 days averaged 28% around pure HA and 51% around HA/Coll implants (p < 0.05). While both implants displayed a good osteoconductivity, a higher bone remodelling activity was observed around collagen-containing HA implants compared to pure HA implants. It appears that the addition of collagen to HA implants can enhance both phagocytotic and osteogenic processes. This may result in an earlier acceptance and better osseointegration of the HA/Coll implants into the surrounding tissue.

Keywords:
Hydroxyapatite, Collagen, Implants, Immunohistochemistry, Osseointegration
1.
Beelen, R.H.J., I.L. Eestermans, E.A. Döpp, C.D. Dijkstra (1987) Monoclonal antibodies ED1, ED2, and ED3 against rat macrophages: Expression of recognized antigens in different stages of differentiation. Transplant Proc 19:3166–3170.
2.
Bloebaum, R.D., D. Beeks, L.D. Dorr, C.G. Savory, J.A. DuPont, A.A. Hofmann (1994) Complications with hydroxyapatite particulate separation in total hip arthroplasty. Clin Orthop 298:19–26.
3.
Blokhuis, T.J., M.F. Termaat, F.C. den Boer, P. Patka, F.C. Bakker, H.J. Haarman (2000) Properties of calcium phosphate ceramics in relation to their in vivo behavior. J Trauma 48:179–186.
4.
Bradt, J.H., M. Mertig, A. Teresiak, W. Pompe (1999) Biomimetic mineralization of collagen by combined fibril assembly and calcium phosphate formation. Chem Mater 11:2694–2701.
5.
Brunel, G., D. Brocard, J.F. Duffort, E. Jacquet, P. Justumus, T. Simonet, E. Benque (2001) Bioabsorbable materials for guided bone regeneration prior to implant placement and 7-year follow-up: Report of 14 cases. J Periodontol 72:257–264.
6.
Caiazza, S., P. Colangelo, R. Bedini, G. Formisano, G. De Angelis, S. Barrucci (2000) Evaluation of guided bone regeneration in rabbit femur using collagen membranes. Implant Dent 9:219–225.
7.
Chapman, M.W., R. Bucholz, C. Cornell (1997) Treatment of acute fractures with a collagen-calcium phosphate graft material. A randomized clinical trial. J Bone Joint Surg Am 79:495–502.
8.
Clarke, K.I., S.E. Graves, A.T.C. Wong, J.T. Triffitt, M.J.O. Francis, J.T. Czernuszka (1993) Investigation into the formation and mechanical properties of a bioactive material based on collagen and calcium phosphate. J Mater Sci Mater Med 4:107–110.
9.
Cui, F.Z., C. Du, X.W. Su, X.D. Zhu, N.M. Zhao (1996) Biodegradation of a nano-hydroxyapatite/collagen composite by peritoneal monocyte-macrophages. Cells Mater 6:31–44.
10.
de Bruijn, J.D., C.A. van Blitterswijk (1998) New developments in implant coatings: Biomimetics and tissue engineering; in Schnettler, G., W. Markgraf (eds): New Developments in Implant Coatings: Biomimetics and Tissue Engineering. Stuttgart, Thieme, pp 77–82.
11.
de Bruijn, J.D., C.A. van Blitterswijk, J.E. Davies (1995) Initial bone matrix formation at the hydroxyapatite interface in vitro. J Biomed Mater Res 29:89–99.
12.
Delecrin, J., S. Takahashi, F. Gouin, N. Passuti (2000) A synthetic porous ceramic as a bone graft substitute in the surgical management of scoliosis: A prospective, randomized study. Spine 25:563–569.
13.
DeLustro, F., J. Dasch, J. Keefe, L. Ellingsworth (1990) Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop 260:263–279.
14.
Denhardt, D.T., C.M. Giachelli, S.R. Rittling (2001) Role of osteopontin in cellular signaling and toxicant injury. Annu Rev Pharmacol Toxicol 41:723–749.
15.
Dodds, R.A., J.R. Connor, I.E. James, E.L. Rykaczewski, E. Appelbaum, E. Dul, M. Gowen (1995) Human osteoclasts, not osteoblasts, deposit osteopontin onto resorption surfaces: An in vitro and ex vivo study of remodeling bone. J Bone Miner Res 10:1666–1680.
16.
Du, C., F.Z. Cui, Q.L. Feng, X.D. Zhu, K. de Groot (1998) Tissue response to nano-hydroxyapatite/collagen composite implants in marrow cavity. J Biomed Mater Res 42:540–548.
17.
Du, C., F.Z. Cui, X.D. Zhu, K. de Groot (1999) Three-dimensional nano-HAp/collagen matrix loading with osteogenic cells in organ culture. J Biomed Mater Res 44:407–415.
18.
Ducheyne, P., Q. Qiu (1999) Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials 20:2287–2303.
19.
Einhorn, T.A. (1998) The cell and molecular biology of fracture healing. Clin Orthop 355 suppl: S7–S21.
20.
Frankenburg, E.P., S.A. Goldstein, T.W. Bauer, S.A. Harris, R.D. Poser (1998) Biomechanical and histological evaluation of a calcium phosphate cement. J Bone Joint Surg Am 80:1112–1124.
21.
Fukase, Y., E.D. Eanes, S. Takagi, L.C. Chow, W.E. Brown (1990) Setting reactins and compressive strengths of calcium phosphate cements. J Dent Res 69:1852–1856.
22.
Hamadouche, M., L. Sedel (2000) Ceramics in orthopaedics. J Bone Joint Surg Br 82:1095–1099.
23.
Hollinger, J.O., J. Brekke, E. Gruskin, D. Lee (1996) Role of bone substitutes. Clin Orthop 324:55–65.
24.
Itoh, S., M. Kikuchi, K. Takakuda, Y. Koyama, H.N. Matsumoto, S. Ichinose, J. Tanaka, T. Kawauchi, K. Shinomiya (2001) The biocompatibility and osteoconductive activity of a novel hydroxyapatite/collagen composite biomaterial, and its function as a carrier of rhBMP-2. J Biomed Mater Res 54:445–453.
25.
Johnson, K.D., K.E. Frierson, T.S. Keller, C. Cook, R. Scheinberg, J. Zerwekh, L. Meyers, M.F. Sciadini (1996) Porous ceramics as bone graft substitutes in long bone defects: A biomechanical, histological, and radiographic analysis. J Orthop Res 14:351–369.
26.
Layman, D.L., R.C. Ardoin (1998) An in vitro system for studying osteointegration of dental implants utilizing cells grown on dense hydroxyapatite disks. J Biomed Mater Res 40:282–290.
27.
Muschler, G.F., S. Negami, A. Hyodo, D. Gaisser, K. Easley, H. Kambic (1996) Evaluation of collagen ceramic composite graft materials in a spinal fusion model. Clin Orthop 328:250–260.
28.
Nakase, T., M. Kaneko, T. Tomita, A. Myoui, K. Ariga, K. Sugamoto, Y. Uchiyama, T. Ochi, H. Yoshikawa (2000) Immunohistochemical detection of cathepsin D, K, and L in the process of endochondral ossification in the human. Histochem Cell Biol 114:21–27.
29.
Nakase, T., M. Sugimoto, M. Sato, M. Kaneko, T. Tomita, K. Sugamoto, S. Nomura, Y. Kitamura, H. Yoshikawa, N. Yasui, K. Yonenobu, T. Ochi (1998) Switch of osteonectin and osteopontin mRNA expression in the process of cartilage-to-bone transition during fracture repair. Acta Histochem 100:287–295.
30.
Okumura, A., M. Goto, T. Goto, M. Yoshinari, S. Masuko, T. Katsuki, T. Tanaka (2001) Substrate affects the initial attachment and subsequent behavior of human osteoblastic cells (Saos-2). Biomaterials 22:2263–2271.
31.
Puleo, D.A., A. Nanci (1999) Understanding and controlling the bone-implant interface. Biomaterials 20:2311–2321.
32.
Rammelt, S., E. Schulze, E. Wolf, D. Scharnweber, M. Holch, H. Worch, H. Zwipp (2002) Immunhistochemical characterisation of the interface on collagen-coated titanium pins in the undecalcified rat tibia. Eur J Trauma 28:125–126.
33.
Roehlecke, C., M. Witt, M. Kasper, E. Schulze, C. Wolf, A. Hofer, R.W. Funk (2001) Synergistic effect of titanium alloy and collagen type I on cell adhesion, proliferation and differentiation of osteoblast-like cells. Cells Tissues Organs 168:178–187.
34.
Sasso, R.C., J.I. Williams, N. Dimasi, P.R. Meyer, Jr. (1998) Postoperative drains at the donor sites of iliac-crest bone grafts. A prospective, randomized study of morbidity at the donor site in patients who had a traumatic injury of the spine. J Bone Joint Surg Am 80:631–635.
35.
Sato, M., N. Yasui, T. Nakase, H. Kawahata, M. Sugimoto, S. Hirota, Y. Kitamura, S. Nomura, T. Ochi (1998) Expression of bone matrix proteins mRNA during distraction osteogenesis. J Bone Miner Res 13:1221–1231.
36.
Schepers, E., M. de Clercq, P. Ducheyne, R. Kempeneers (1991) Bioactive glass particulate material as a filler for bone lesions. J Oral Rehabil 18:439–452.
37.
Schulze, E., M. Witt, M. Kasper, C.W. Lowrik, R.W.H. Funk (1999) Immunohistochemical investigations on the differentiation marker protein E 11 in rat calvaria, calvaria cell culture and the osteoblastic cell line ROS 17/2.8. Histochem Cell Biol 111:61–69.
38.
Sun, J.S., F.H. Lin, T.Y. Hung, Y.H. Tsuang, W.H. Chang, H.C. Liu (1999) The influence of hydroxyapatite particles on osteoclast cell activities. J Biomed Mater Res 45:311–321.
39.
TenHuisen, K.S., R.I. Martin, M. Klimkiewicz, P.W. Brown (1995) Formation and properties of a synthetic bone composite: Hydroxyapatite-collagen. J Biomed Mater Res 29:803–810.
40.
Terai, K., T. Takano-Yamamoto, Y. Ohba, K. Hiura, M. Sugimoto, M. Sato, H. Kawahata, N. Inaguma, Y. Kitamura, S. Nomura (1999) Role of osteopontin in bone remodelling caused by mechanical stress. J Bone Mineral Res 14:839–849.
41.
Trentz, O.A., R. Zellweger, M.G. Amgwerd, G.K. Uhlschmid (1997) Testing bone implants in cell lines and human osteoblasts. Unfallchirurg 100:39–43.
42.
Vigorita, V.J., B. Ghelman (1999) Orthopaedic Pathology. Philadelphia, Lippincott Williams & Wilkins.
43.
Walsh, W.R., J. Harrison, A. Loefler, T. Martin, D. Van Sickle, M.K. Brown, D.H. Sonnabend (2000) Mechanical and histologic evaluation of Collagraft in an ovine lumbar fusion model. Clin Orthop 375:258–266.
44.
Wolfe, S.W., L. Pike, J.F. Slade, 3rd, L.D. Katz (1999) Augmentation of distal radius fracture fixation with coralline hydroxyapatite bone graft substitute. J Hand Surg 24:816–827.
45.
Yamazaki, M., F. Nakajima, A. Ogasawara, H. Moriya, R.J. Majeska, T.A. Einhorn (1999) Spatial and temporal distribution of CD44 and osteopontin in fracture callus. J Bone Joint Surg Br 81:508–515.
46.
Yang, R.S., T.K. Liu (1998) Immunohistochemical analysis of matrix proteolytic enzymes in the periprosthetic tissue in the patients with loosening prostheses. Tohoku J Exp Med 184:99–111.
47.
Younger, E.M., M.W. Chapman (1989) Morbidity at bone graft donor sites. J Orthop Trauma 3:192–195.
48.
Zambonin, G., M. Grano (1995) Biomaterials in orthopaedic surgery: Effects of different hydroxyapatites and demineralized bone matrix on proliferation rate and bone matrix synthesis by human osteoblasts. Biomaterials 16:397–402.
49.
Zwipp, H., R. Grass, S. Rammelt, C. Dahlen (1999) Arthrodesis – Non-union of the ankle. Arthrodesis failed. Chirurg 70:1216–1224.
© 2004 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.